English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
 DetailsSummary
  Antibodies for prevention and treatment of diseases caused by Clostridium difficile

Seeberger, P. H., Martin, C. E., Bröcker, F., & Chakkumkal, A.(2016). Antibodies for prevention and treatment of diseases caused by Clostridium difficile.

Item is

 

show all hide all

Basic

show hide
Item Permalink: https://hdl.handle.net/11858/00-001M-0000-002C-0391-E Version Permalink: https://hdl.handle.net/21.11116/0000-0000-6402-D
Genre: Patent

Files

show Files
hide Files
:
2364357.pdf (Publisher version), 3MB
View   Save
File Permalink:
https://hdl.handle.net/11858/00-001M-0000-002C-0393-A
Name:
2364357.pdf
Description:
-
OA-Status:
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
View
Copyright Date:
-
Copyright Info:
-
License:
-

Locators

show

Creators

show
hide
 Creators:
Seeberger, Peter H.1, Author           
Martin, Christopher E.2, Author           
Bröcker, Felix3, Author           
Chakkumkal, Anish3, Author           
Affiliations:
1Peter H. Seeberger, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society, ou_2040285              
2Peter H. Seeberger - Vaccine Development, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society, ou_1863308              
3Chakkumal Anish, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society, ou_1863299              

Content

show
hide
Free keywords: -
 Abstract: The present invention relates to an antibody having specificity for an immunogenic determinant consisting of the pentasaccharide repeating unit of the Clostridium difficile glycopolymer PS-I: α-L-Rhap-(1→3)-β-D-Glcp-(1→4)-[α-L-Rhap-(1→3)]-α-D-Glcp-(1→2)-α-D-Glcp or a fragment thereof. Said antibody is able to prevent and treat diseases caused by C. difficile. The present invention further pertains to a method of treating or preventing a disease caused by the pathogen Clostridium difficile, which comprises administering to a subject said antibody or a vaccine composition comprising said antibody.

Details

show
hide
Language(s):
 Dates: 2015-12-102016-05-19
 Publication Status: Published online
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: Patent Publication Nr.: US20160137724 A1
Patent Application Nr.: US201514964763
 Degree: -

Event

show

Legal Case

show

Project information

show

Source

show